179 related articles for article (PubMed ID: 33739218)
1. Safety and oncological outcome following radiofrequency ablation of small renal masses in a single center.
Bersang AB; Søndergaard Mosholt KS; Verner Jensen C; Germer U; Holm M; Røder MA
Scand J Urol; 2021 Jun; 55(3):203-208. PubMed ID: 33739218
[TBL] [Abstract][Full Text] [Related]
2. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
[TBL] [Abstract][Full Text] [Related]
3. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
4. Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.
Wessendorf J; König A; Heers H; Mahnken AH
Cardiovasc Intervent Radiol; 2021 Dec; 44(12):2022-2025. PubMed ID: 34414496
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Ablation Versus Nephrectomy for Small Renal Masses: Clinical Outcomes in a Single-Center Cohort.
Lourenco P; Bilbey N; Gong B; Bahrabadi A; Halkier B
Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1892-1900. PubMed ID: 30088062
[TBL] [Abstract][Full Text] [Related]
6. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up.
Beland MD; Wolf FJ; Grand DJ; Dupuy DE; Mayo-Smith WW
AJR Am J Roentgenol; 2011 Sep; 197(3):671-5. PubMed ID: 21862810
[TBL] [Abstract][Full Text] [Related]
7. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
8. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous radiofrequency ablation is an effective treatment option for small renal masses, comparable to partial nephrectomy.
Pedraza-Sánchez JP; Chaves-Marcos R; Mazuecos-Quirós J; Bisonó-Castillo ÁL; Osmán-García I; Gutiérrez-Marín CM; Medina López RA; Juárez Soto Á
Eur Radiol; 2023 Nov; 33(11):7371-7379. PubMed ID: 37280356
[TBL] [Abstract][Full Text] [Related]
10. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
Ma Y; Bedir S; Cadeddu JA; Gahan JC
BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
[TBL] [Abstract][Full Text] [Related]
13. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
17. Oncological and Functional Outcomes of Laparoscopic Radiofrequency Ablation and Partial Nephrectomy for T1a Renal Masses: A Retrospective Single-center 60 Month Follow-up Cohort Study.
Park JM; Yang SW; Shin JH; Na YG; Song KH; Lim JS
Urol J; 2019 Feb; 16(1):44-49. PubMed ID: 30120758
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
19. [Long-term follow-up of renal cell carcinomas T1a treated by percutaneous radiofrequency].
Amadane N; André M; Daniel L; Coulange C; Baboudjian M; Michel F; Gondran-Tellier B; Vanacore D; Lechevallier E; Boissier R
Prog Urol; 2021 Sep; 31(10):576-583. PubMed ID: 33593696
[TBL] [Abstract][Full Text] [Related]
20. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
